KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to $764.4 million.

  • Jazz Pharmaceuticals' Receivables - Net rose 562.78% to $764.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $764.4 million, marking a year-over-year increase of 562.78%. This contributed to the annual value of $716.8 million for FY2024, which is 155.44% up from last year.
  • As of Q3 2025, Jazz Pharmaceuticals' Receivables - Net stood at $764.4 million, which was up 562.78% from $714.0 million recorded in Q2 2025.
  • Jazz Pharmaceuticals' Receivables - Net's 5-year high stood at $764.4 million during Q3 2025, with a 5-year trough of $414.0 million in Q1 2021.
  • Moreover, its 5-year median value for Receivables - Net was $627.8 million (2023), whereas its average is $628.8 million.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Receivables - Net skyrocketed by 4397.02% in 2021, and later plummeted by 765.14% in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Receivables - Net (Quarter) stood at $563.4 million in 2021, then rose by 15.64% to $651.5 million in 2022, then rose by 8.33% to $705.8 million in 2023, then rose by 1.55% to $716.8 million in 2024, then grew by 6.64% to $764.4 million in 2025.
  • Its Receivables - Net was $764.4 million in Q3 2025, compared to $714.0 million in Q2 2025 and $653.0 million in Q1 2025.